Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

Journal of the National Cancer Institute

Volumn 90, Issue 15, 1998, Pages 1138-1145

  Lakhani, Sunil R ^a   Jacquemier, Jocelyne ^b   Sloane, John P ^c   Gusterson, Barry A ^d   Anderson, Thomas J ^e   Van De Vijver, Marc J ^f   Farid, Linda M ^g   Venter, Deon ^h,i   Antoniou, Antonios ^j   Storfer Isser, Amy ^k   Smyth, Elizabeth ^l   Steel, C Michael ^m   Haites, Neva ⁿ   Scott, Rodney J ^o   Goldgar, David ^p   Neuhausen, Susan ^q   Daly, Peter A ^r   Ormiston, Wilma ^r   McManus, Ross ^r   Scherneck, Siegfried ^s   Ponder, Bruce A J ^t   Ford, Debbie ^d   Peto, Julian ^d   Stoppa Lyonnet, Dominique ^u   Bignon, Yves Jean ^v   Struewing, Jeffery P ^w   Spurr, Nigel K ^k   Bishop, D Timothy ^x   Klijn, J G M ^y   Devilee, Peter ^z   Cornelisse, Cees J ^z   Lasset, Christine ^aa   Lenoir, Gilbert ^p   Barkardottir, Rosa Bjork ^ab   Egilsson, Valgardur ^ab   Hamann, Ute ^ac   Chang Claude, Jenny ^ac   Sobol, Hagay ^b   Weber, Barbara ^ad   Stratton, Michael R ^d   Easton, Douglas F ^k   more..

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b INSTITUT PAOLI CALMETTES   (France)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f NETHERLANDS CANCER INSTITUTE   (Netherlands)

^g HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^h PETER MACCALLUM CANCER CENTRE   (Australia)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

^j UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^k IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^l WESTERN GENERAL HOSPITAL   (United Kingdom)

^m UNIVERSITY OF ST ANDREWS   (United Kingdom)

ⁿ UNIVERSITY OF ABERDEEN   (United Kingdom)

^o UNIVERSITY HOSPITAL BASEL   (Switzerland)

^p INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^q UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^r TRINITY COLLEGE DUBLIN   (Ireland)

^s MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^t ADDENBROOKE S HOSPITAL   (United Kingdom)

^u INSTITUT CURIE   (France)

^v CENTRE JEAN PERRIN   (France)

^w NATIONAL CANCER INSTITUTE   (United States)

^x ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^y ERASMUS MEDICAL CENTER   (Netherlands)

^z LEIDEN UNIVERSITY   (Netherlands)

^aa CENTRE LÉON BÉRARD   (France)

^ab LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^ac GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ad UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST CANCER; CANCER GENETICS; CONTROLLED STUDY; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; PATHOLOGIST; STATISTICAL ANALYSIS;

EID: 0032486752     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.15.1138     Document Type: Article

References (31)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
2. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2 [published erratum appears in Nature 1996;379:749]. Nature 1995;378:789-92.
3. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990;250:1684-9.
4. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994;265:2088-90.
5. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet 1997;349:1505-10.
6. Eisinger F, Stoppa-Lyonnet D, Longy M, Kerangueven F, Noguchi T, Bailly C, et al. Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res 1996;56:471-4.
7. Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P, et al. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 1996;77:697-709.
8. National Coordinating Group for Breast Screening Pathology. Pathology reporting in breast cancer screening. National Health Service Breast Screening Program Publication No. 3 (2nd ed.). Sheffield (U.K.): National Health Service Breast Screening Program, 1995.
9. Ridolfi RL, Rosen PP, Port A, Kinne D, Mike V. Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up. Cancer 1977; 40:1365-85.
10. Rigaud C, Theobald S, Noel P, Badreddine J, Barlier C, Delobelle A, et al. Medullary carcinoma of the breast. A multicenter study of its diagnostic consistency. Arch Pathol Lab Med 1943;117:1005-8.
11. Pedersen L, Holck S, Schiodt T, Zedeler K, Mouridsen HT. Inter- and intraobserver variability in the histopathological diagnosis of medullary carcinoma of the breast, and its prognostic implications. Breast Cancer Res Treat 1989;14:91-9.
12. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998;62:676-89.
13. Breslow NE, Day NE. Statistical methods in cancer Research. Volume I - The analysis of case-control studies. IARC Sci Publ 1980;32:5-338.
14. Huber PJ. The behaviour of maximum likelihood estimates under non standard conditions. In: Proceedings 5th Berkeley Symposium on Mathematics, Statistics, and Probability. Stat Prob 1967;1:221-33.
15. Efron B, Tibishirani R. An introduction to the bootstrap. New York: Chapman & Hall, 1993.
16. Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995;57:1457-62.
17. Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King MC, et al. Growth retardation and tumor inhibition by BRCA1. Nat Genet 1996;12:298-302
18. Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 1995;9:444-50.
19. Ruffner H, Verma IM. BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc Natl Acad Sci USA 1997;94:7138-43.
20. Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 1997;88:265-75.
21. Porter DE, Cohen BB, Wallace MR, Smyth E, Chetty U, Dixon JM, et al. Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br J Surg 1994;81:1512-5.
22. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 1996;12:333-7.
23. Connor F, Smith A, Wooster R, Stratton M, Dixon A, Campbell E, et al. Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene. Hum Mol Genet 1997;6:291-300.
24. Abel KJ, Xu J, Yin GY, Lyons RH, Meisler MH, Weber BL. Mouse Brca1: localization sequence analysis and identification of evolutionarily conserved domains. Hum Mol Genet 1995;4:2265-73.
25. Milner J, Ponder B, Hughes-Davies L, Seltmann M, Kouzarides T. Transcriptional activation functions in BRCA2 [letter]. Nature 1997;386:772-3.
26. Chapman MS, Verma IM. Transcriptional activation by BRCA1 [letter]. Nature 1996;382:678-9.
27. Sharan SK, Morimatsu M, Albrecht U, Lim DS, Regel E, Dinh C, et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 1997;386:804-10.
28. Gowen LC, Johnson BL, Latour AM, Sulik KK, Koller BH. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet 1996;12:191-4.
29. Vaughn JP, Cirisano FD, Huper G, Berchuck A, Futreal PA, Marks JR, et al. Cell cycle control of BRCA2. Cancer Res 1996;56:4590-4.
30. Easton DF, Steele L, Fields P, Ormiston W, Averill D, Daly PA, et al. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet 1997;61:120-8.
31. Phelan CM, Lancaster JM, Tonin P, Gumbs C, Cochran C, Carter R, et al. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families [published erratum appears in Nat Genet 1996;13:16-7]. Nat Genet 1996;13:120-2.